<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>School of Public Health</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/33B346AB-40B3-44A5-ACC5-C74B3D1E4CFE"><gtr:id>33B346AB-40B3-44A5-ACC5-C74B3D1E4CFE</gtr:id><gtr:firstName>Tihana</gtr:firstName><gtr:surname>Bicanic</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A447739F-1768-4AF7-A1CD-D607232B37CB"><gtr:id>A447739F-1768-4AF7-A1CD-D607232B37CB</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Anne</gtr:otherNames><gtr:surname>Butcher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A4597D2C-1C22-494E-884D-AE6353E6CA20"><gtr:id>A4597D2C-1C22-494E-884D-AE6353E6CA20</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>C.</gtr:otherNames><gtr:surname>Fisher</gtr:surname><gtr:orcidId>0000-0002-1862-6402</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7F8BECA8-61D8-4755-A7C4-7D93F99D0C71"><gtr:id>7F8BECA8-61D8-4755-A7C4-7D93F99D0C71</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>Arthur</gtr:otherNames><gtr:surname>Henk</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CDFAE137-278C-4FF5-B0AE-A28CA574E1FF"><gtr:id>CDFAE137-278C-4FF5-B0AE-A28CA574E1FF</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:surname>Harrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FK000373%2F1"><gtr:id>5A2A6E07-4732-41AE-836B-5EA00CDCA83F</gtr:id><gtr:title>An evolutionary population genomics approach to determine the genetic basis of virulence in the pathogenic fungus Cryptococcus neoformans</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K000373/1</gtr:grantReference><gtr:abstractText>Infectious fungi are causing an increasing burden of disease worldwide. The fungus Cryptococcus neoformans infects individuals with damaged immune systems, such as those suffering from HIV/AIDS, commonly resulting in meningitis. This pathogen has become one of the leading fungal causes of disease and death worldwide, causing a million infections per year and 15-20% of all AIDS-related deaths. Research has shown that the ability to successfully infect, and to cause disease (virulence), largely depends on the DNA sequence (genotype) of the infecting Cryptococcus strain, and that a specific lineage (known as VNI) has undergone an ecological transition from a tree-associated wood-decaying organism to a bird-associated human pathogen. We have dated the emergence of this pandemic lineage out of Africa to colonise the world within the last 5,000 years. There is now an opportunity to determine how this emergence occurred, by sequencing the genomes of many environmental strains of C. neoformans and comparing their genetic diversity to that found causing disease in HIV patients worldwide. Our study will characterise the the genomic diversity of infecting Cryptococcus strains from HIV patients in affected regions of sub-saharan Africa and Southeast Asia. The African patients are being enrolled in a newly-funded MRC trial on the efficacy of antifungal drugs against cryptococcosis. We will collect isolates of C. neoformans from their environmental reservoir, trees, across South East Asia (principally Thailand) and sub-Saharan Africa, and compare their genome sequences to those known to cause disease in human patients. This will allow us to identify the genomic regions that are associated with virulence in humans, and will date major evolutionary events in C. neoformans, including the shuffling of genes through sexual recombination, how many lineages emerged from Africa to colonise the world, and when this occurred. Importantly, we will profile our environmental versus clinical infectious isolates with respect to key virulence determinants including size and shedding of their capsule, their ability to invade and grow within human macrophage cells and their ability to kill the model insect species Galleria mellonella. For isolates that show significant differences in virulence, we will profile patterns of gene expression for isolates cultured under conditions that mimic infection. These results will provide novel insights into diverse virulence determinants, some of which may provide new therapeutic targets against this difficult to treat infection.</gtr:abstractText><gtr:technicalSummary>We will use our cryopreserved collection of &amp;gt;300 clinical and environmental MLST-profiled Cng isolates from SE Asia and Africa to sequence isolates, including the reference H99, to a depth of ~100x. Reads will be aligned to the Broad Institute Cng VNI H99 reference genome to allow assembly, and base-calling. SNPs that are entirely covered in all isolates with high confidence will be concatenated for final alignment against the H99 chromosomes to produce a super-alignment. Aneuploid contigs will be treated as heterozygotes and detected using a depth-dependent binomial technique. In tandem with bioinformatics development, we will continue to expand our collection of environmental isolates from Southern Africa and SE Asia in collaboration with MRC-funded trials. Isolates will be Illumina-sequenced and sequentially added to the population genomics database. These will then be subjected to a genomics analysis aimed at determining the patterns and processes that have led to contemporary distributions of genetic diversity for global Cng. Associations will be sought between genotype and virulence by using clinical vs environmental isolates and, within clinical isolates, using the detailed clinical outcome data available for the source patients. Functional characterisation of outbreak clinical versus arboreal/environmental isolates will be done using the established Cng virulence factors, and a high-throughput analysis of macrophage parasitism using an intracellular proliferation rate assay for representatives of each Cng genotype. Virulence will also be assessed utilising the waxmoth larvae as a surrogate for murine models. Lineage-specific phenotypes will be analysed and panels of isolates that exhibit virulent versus hypovirulent phenotypes will be subjected to analysis of gene-expression using RNAseq. This will set the stage for downstream QTL-mapping of virulence in this sexually-reproducing fungus and the discovery of novel pathogen effectors.</gtr:technicalSummary><gtr:potentialImpactText>We are concerned that insufficient development has occurred to appropriately disburse the avalanche of population genomics data that is being released by next-generation technologies, and even major repositories such as the NCBI Short Read Archive are finding it difficult to sustain adequate funding and resources. In order to counter this deficit, and to capitalise on the potential for population genomics datasets to transform evolutionary epidemiology, significant cross-disciplinary work needs to occur between partners for the full impact of next-generation genomics to be manifested. We will capitalise on our extensive expertise in bioinformatics, high-performance computing, statistical genetics, wet-lab and field-epidemiology and clinical trials to provide informatics solutions to allow community-wide access to the datasets and informatics tools that we are developing. As such, the wider epidemiological community stands to benefit from our research as our informatics platforms grow from our current investments.

Government and NGO charities in areas that are struck by the HIV pandemic will make use of our data on the distribution of Cryptococcus pathogenicity. As it is unlikely that people can be protected from aerosol-infection of environmental Cryptocococcus, our work is specifically targeted at identifying the aspects of the cryptococcal genome that are important in virulence, with the hope that we can use this information to develop targeted therapeutics. There are currently only three classes of antifungal agents with activity against Cryptococcus, with only one drug per class in common usage for treatment of cryptococcal meningitis. The newest of these, fluconazole, was licensed in 1993, and is poorly fungicidal and associated with secondary resistance. There is an urgent need for novel antifungal drug targets and adjunctive therapies, as well as for drugs with improved safety and tolerability profiles. Fungal pathogen genetics is currently at a turning point owing to the discovery of previously unsuspected virulence effectors, related to the RxLxE/Q/D motifs recently uncovered in Plasmodium. The potential discovery of similar virulence effectors in Cryptococcus may yield completely novel, untried, antifungal drug targets that could be exploited by industry to add to our scant armamentarium of antifungal drugs.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-12-17</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-09-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>562640</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MIT Broad Institute</gtr:description><gtr:id>4FF5FF83-BC8A-43FE-B806-B30A64FBE0C4</gtr:id><gtr:impact>Paper in submission</gtr:impact><gtr:partnerContribution>Contribution of whole genome sequences of Cryptococcus neoformans and analysis.</gtr:partnerContribution><gtr:piContribution>Contribution of whole genome sequences of Cryptococcus neoformans, analysis and experimental data</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The Broad Institute Genomics Collaboration</gtr:description><gtr:id>F88FBCBE-09C5-4D2E-9096-C2CA4B26C3E7</gtr:id><gtr:impact>Manuscripts in preparation</gtr:impact><gtr:partnerContribution>De Novo techniques for whole genome sequencing of Cryptococcus</gtr:partnerContribution><gtr:piContribution>Whole Genome Sequencing and Analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CDC Outbreak</gtr:description><gtr:id>EA341A78-A57C-4C19-BE49-A0E3A6943F3E</gtr:id><gtr:impact>Ongoing manuscript preparation</gtr:impact><gtr:partnerContribution>Methodological and technological advances</gtr:partnerContribution><gtr:piContribution>Developing rapid methodologies for analysis of fungal disease outbreaks</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/89C90593-18E5-4A6F-B949-BF42B8E265DD"><gtr:id>89C90593-18E5-4A6F-B949-BF42B8E265DD</gtr:id><gtr:title>Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd25cc72e5d1a383b7c7011b5c515b14"><gtr:id>dd25cc72e5d1a383b7c7011b5c515b14</gtr:id><gtr:otherNames>Engelthaler DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7F80410-9B5D-4504-A0F4-1C0655E83E0D"><gtr:id>E7F80410-9B5D-4504-A0F4-1C0655E83E0D</gtr:id><gtr:title>Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/adf5d27803697e770cac47374260e978"><gtr:id>adf5d27803697e770cac47374260e978</gtr:id><gtr:otherNames>Farrer RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7248C23-7EA7-4690-AC6E-CF003D6507D0"><gtr:id>D7248C23-7EA7-4690-AC6E-CF003D6507D0</gtr:id><gtr:title>The Case for Adopting the &amp;quot;Species Complex&amp;quot; Nomenclature for the Etiologic Agents of Cryptococcosis.</gtr:title><gtr:parentPublicationTitle>mSphere</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d4d846ceffc457212d56ea33c30a096c"><gtr:id>d4d846ceffc457212d56ea33c30a096c</gtr:id><gtr:otherNames>Kwon-Chung KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-5042</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC7A3BA5-AAA8-4523-948B-1A9C3D51AE61"><gtr:id>FC7A3BA5-AAA8-4523-948B-1A9C3D51AE61</gtr:id><gtr:title>Erratum for Abdolrasouli et al., Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/881f0dc661d09f321806e0708336a550"><gtr:id>881f0dc661d09f321806e0708336a550</gtr:id><gtr:otherNames>Abdolrasouli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/764BC0D3-07EA-486B-9429-00B35DBA4D50"><gtr:id>764BC0D3-07EA-486B-9429-00B35DBA4D50</gtr:id><gtr:title>A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection.</gtr:title><gtr:parentPublicationTitle>G3 (Bethesda, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ab8460996ce31ee6ba48f6f3f4fc581"><gtr:id>6ab8460996ce31ee6ba48f6f3f4fc581</gtr:id><gtr:otherNames>Rhodes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2160-1836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/178062B9-6281-4029-8460-868383A66E29"><gtr:id>178062B9-6281-4029-8460-868383A66E29</gtr:id><gtr:title>Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7bcb43cf20e9a525a55b6101778520c9"><gtr:id>7bcb43cf20e9a525a55b6101778520c9</gtr:id><gtr:otherNames>Beale MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0199F27D-4EB7-438B-9148-4059ECA4C555"><gtr:id>0199F27D-4EB7-438B-9148-4059ECA4C555</gtr:id><gtr:title>Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/881f0dc661d09f321806e0708336a550"><gtr:id>881f0dc661d09f321806e0708336a550</gtr:id><gtr:otherNames>Abdolrasouli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DEE0AEA8-A163-4035-B8D5-A96F248F7D7B"><gtr:id>DEE0AEA8-A163-4035-B8D5-A96F248F7D7B</gtr:id><gtr:title>Geographically structured populations of Cryptococcus neoformans Variety grubii in Asia correlate with HIV status and show a clonal population structure.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/442b7f096acdd3d516581ab064e351f2"><gtr:id>442b7f096acdd3d516581ab064e351f2</gtr:id><gtr:otherNames>Khayhan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75EDFC06-17F9-4310-83F2-FF1FAFA0A73B"><gtr:id>75EDFC06-17F9-4310-83F2-FF1FAFA0A73B</gtr:id><gtr:title>Genomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV/AIDS cohort.</gtr:title><gtr:parentPublicationTitle>Molecular ecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2728327ea8fc60be7cea31db6aa8e95"><gtr:id>e2728327ea8fc60be7cea31db6aa8e95</gtr:id><gtr:otherNames>Vanhove M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0962-1083</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A056A4B2-F1E7-4BC0-9A32-31EAD882ED39"><gtr:id>A056A4B2-F1E7-4BC0-9A32-31EAD882ED39</gtr:id><gtr:title>Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35233ed9adaf19841a3034fd01bb9467"><gtr:id>35233ed9adaf19841a3034fd01bb9467</gtr:id><gtr:otherNames>Shah A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/653D7744-2F6C-4C5C-976E-1D21E21BE542"><gtr:id>653D7744-2F6C-4C5C-976E-1D21E21BE542</gtr:id><gtr:title>Illuminating choices for library prep: a comparison of library preparation methods for whole genome sequencing of Cryptococcus neoformans using Illumina HiSeq.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ab8460996ce31ee6ba48f6f3f4fc581"><gtr:id>6ab8460996ce31ee6ba48f6f3f4fc581</gtr:id><gtr:otherNames>Rhodes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BF8E0DA-F865-40C1-955D-EAEB9889C0DD"><gtr:id>2BF8E0DA-F865-40C1-955D-EAEB9889C0DD</gtr:id><gtr:title>Cryptococcus neoformans molecular type VNB is associated with mortality in HIV associated cryptococcal meningitis in South Africa</gtr:title><gtr:parentPublicationTitle>MYCOSES</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/490945be3f0f1a8636e2952be98e5a59"><gtr:id>490945be3f0f1a8636e2952be98e5a59</gtr:id><gtr:otherNames>Beale M. A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0933-7407</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/73E90C67-E1E0-4B4D-8800-BE9C8562AEE7"><gtr:id>73E90C67-E1E0-4B4D-8800-BE9C8562AEE7</gtr:id><gtr:title>Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b509571ce35681e0c2b4e609b747c728"><gtr:id>b509571ce35681e0c2b4e609b747c728</gtr:id><gtr:otherNames>Sabiiti W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75E003BB-8B5C-4698-A279-C73AB49C1D53"><gtr:id>75E003BB-8B5C-4698-A279-C73AB49C1D53</gtr:id><gtr:title>Transmission of Hypervirulence traits via sexual reproduction within and between lineages of the human fungal pathogen cryptococcus gattii.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c785f6eb306ac4299dab556c4c0a6633"><gtr:id>c785f6eb306ac4299dab556c4c0a6633</gtr:id><gtr:otherNames>Voelz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K000373/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>